SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-283824
Filing Date
2015-08-10
Accepted
2015-08-10 07:01:34
Documents
3
Period of Report
2015-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d72521d8k.htm 8-K 14855
2 EX-99.1 d72521dex991.htm EX-99.1 71064
3 GRAPHIC g72521g13y62.jpg GRAPHIC 5324
  Complete submission text file 0001193125-15-283824.txt   94827
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 151039161
SIC: 3841 Surgical & Medical Instruments & Apparatus